Morton-Jones T, Pringle M
Department of General Practice, Queen's Medical Centre, Nottingham.
BMJ. 1993 Jun 26;306(6894):1731-4. doi: 10.1136/bmj.306.6894.1731.
To derive a predictive model for national prescribing behaviour in terms of basic morbidity and demographic factors.
24 demographic, morbidity, and practice factors were entered into a multiple regression analysis to determine the net ingredient cost per patient.
The 90 family health service authorities in England for 1989.
For net ingredient cost per patient only two demographic factors (numbers of pensioners and the mobility of the registered population measured by list inflation) and two morbidity related factors (standardised mortality ratios and numbers of prepayment certificates issued) significantly contributed to a multiple regression model. This model explained 81% of the variation in net ingredient cost per registered patient between family health services authorities. The model also enabled a weighting factor of 4.6 (95% confidence interval 3.2 to 6.7) to be derived for the net ingredient cost for elderly patients (compared with the existing prescribing unit factor of 3).
The model shows that variations in prescribing costs essentially reflect demand. It also suggests that the current prescribing unit value of 3 for patients aged 65 or more underestimates the extra costs of prescribing for elderly patients.
根据基本发病率和人口统计学因素推导国家处方行为的预测模型。
将24个人口统计学、发病率和实践因素纳入多元回归分析,以确定每位患者的净药品成本。
1989年英格兰的90个家庭健康服务机构。
对于每位患者的净药品成本,仅有两个人口统计学因素(领取养老金者人数以及通过名单膨胀衡量的登记人口流动性)和两个与发病率相关的因素(标准化死亡率和预付费证书发放数量)对多元回归模型有显著贡献。该模型解释了家庭健康服务机构之间每位登记患者净药品成本变化的81%。该模型还得出老年患者净药品成本的加权因子为4.6(95%置信区间3.2至6.7)(与现有的处方单位因子3相比)。
该模型表明处方成本的差异本质上反映了需求。它还表明,目前65岁及以上患者3的处方单位价值低估了老年患者的额外处方成本。